Dark Forest Capital Management LP Natera, Inc. Transaction History

Dark Forest Capital Management LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$36.57 - $58.29 $121,375 - $193,464	3,319 New	3,319 $184,000
Q2 2022 Aug 15, 2022	SELL	$28.13 - $44.54 $179,722 - $284,566	-6,389 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$30.32 - $91.33 $190,106 - $572,639	6,270 Added 5268.91%	6,389 $260,000
Q4 2021 Feb 11, 2022	SELL	$86.26 - $119.0 $216,771 - $299,047	-2,513 Reduced 95.48%	119 $11,000
Q3 2021 Nov 12, 2021	BUY	$100.17 - $126.36 $263,647 - $332,579	2,632 New	2,632 $293,000

528

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $16.3B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.